Uncategorized AstraZeneca – MedImmune strengthens immune-mediated cancer therapy portfolio with acquisition of Amplimmune AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire…Super UserAugust 26, 2013
Uncategorized MIMETAS Appoints Biotech Pioneer Herbert Heyneker as Chairman of the Board MIMETAS today announces the appointment of Herbert L. Heyneker, Ph.D. as Chairman of the Board of Directors. Dr. Heyneker will…Super UserJuly 24, 2013
Uncategorized MIMETAS wins LifeSciences@Work award Maarssen, the Netherlands, 14 June 2013 - MIMETAS was awarded the prestigious LifeSciences@Work award during yesterdays' Dutch Life Sciences SME…Super UserJune 14, 2013